Jung, Wonyeong
Yuan, Dansu
Kellman, Benjamin http://orcid.org/0000-0002-0780-6096
Gonzalez, Isabela Garrido da Silva
Clemens, Ralf http://orcid.org/0000-0003-4685-4207
Milan, Eveline Pipolo http://orcid.org/0000-0002-5443-6315
Sprinz, Eduardo http://orcid.org/0000-0003-4343-8304
Cerbino Neto, José http://orcid.org/0000-0001-9254-917X
Smolenov, Igor
Alter, Galit http://orcid.org/0000-0002-7680-9215
McNamara, Ryan P. http://orcid.org/0000-0002-8866-3532
Costa Clemens, Sue Ann http://orcid.org/0000-0001-9576-0878
Funding for this research was provided by:
Bill and Melinda Gates Foundation (INV-030336, INV-030336)
The Samana Kay MGH Research Scholars fund
Bill and Melinda Gates Foundation
Article History
Received: 15 May 2023
Accepted: 8 December 2023
First Online: 5 January 2024
Competing interests
: G.A. is an employee of Moderna Therapeutics and holds equity in Leyden Labs and Seromyx Systems. I.S. is a full-time employee of Clover Biopharmaceuticals. R.C. is a scientific adviser for Clover Biopharmaceuticals. S.A.C.C. is a member of the Oxford Vaccine Group and was involved in the development of the ChadOx-1 vaccine; she is also a scientific adviser for Clover Biopharmaceuticals.